Method of treating leukemia
AssigneeEpizyme, Inc.
InventorsEdward J. Olhava, Richard Chesworth, Kevin W. Kuntz, Victoria M. Richon, Roy M. Pollock, Scott Richard Daigle
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of treating disorders in which DOT1L-mediated protein methylation plays a part, such as cancer, by administering DOT1L inhibitor compounds and pharmaceutical compositions to subjects in need thereof.
Claims13
A method for treating cancer comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or its N-oxide or a pharmaceutically acceptable salt thereof:
- wherein the subject had at least one prior therapy to treat a hematological cancer.
A method for treating cancer comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I) or its N-oxide or a pharmaceutically acceptable salt thereof:
- wherein the subject is unable to receive other therapy to treat the cancer due to age or intercurrent illness.
Dependencies are inferred from the claim text.